New drug target offers hope in fight against antibiotic-resistant E. coli

Dr Joanne Lemieux's research team, led by Dr. Jimmy Lu, published a paper in Nature Communications identifying a new drug target to treat harmful E. coli bacteria. Their work was recently highlighted in the Folio.

20 February 2026

Exciting new publication from Dr. Joanne Lemieux's lab was featured in the February 18, 2026 edition of the Folio. The article "U of A lab identifies a way to switch off the bacteria’s protective shield" written by Gillian Rutherford highlights the recent Nature Communications publication entitled "Rhomboid protease GlpG regulates type 1 pili quality control and virulence in pathogenic E. coli"